|
Impact of vitamin D deficiency on severity, inflammation and fibrosis
in alcoholic liver disease.
E. Trépo (1), R. Ouziel (1), P. Pradat (2), Y. Momozawa (3), E. Quertinmont (1), C. Gervy (1), T. Gustot (1), D. Degré (1), V. Vercruysse (1), P. Deltenre (4), B. Gulbis (1), D. Franchimont (1), J. Devière (1), A. Lemmers (1), C. Moreno (1) / [1] UL B Erasme, Brussels, [2] La Croix-Rousse Hospital, Lyon, France, [3] UL g [4] Hôpital de Jolimont, Haine-Saint-Paul
Histopathological parameters are associated with both severity and
survival in alcoholic hepatitis.
L. Verset, E. Trepo, N. Nagy, D. Degre, T. Gustot, J. Deviere, P. Demetter, C. Moreno / UL B Erasme, Brussels
Severe hyponatremia is the best predictor of mortality in cirrhosis
and refractory ascites.
T. Sersté (1), T. Gustot (2), P.E. Rautou (3), C. Francoz (3), H. Njimi (2), F. Durand (3), D. Valla (3), D. Lebrec (3), R. Moreau (3) / [1] Ulb Saint-Pierre, Brussels, [2] UL B Erasme, Brussels, [3] Hôpital Beaujon, Clichy, France
Normal versus elevated alt and ggt in an obese population,
association with liver histology.
A. Verrijken, S. Francque, I. Mertens, M. Ruppert, G. Hubens, E. Van Marck,
P. Michielsen, L. Van Gaal / UZAntwerp
Enhanced Sepsis-Associated Mortality of Patients with Cirrhosis in ICU: EPIC II study. T. Gustot, H. Njimi, F. Taccone, C. Moreno, J.L. Vincent / Ulb Erasme, Brussels
Efficacy of boceprevir in patients with null responses to peginterferon/ribavirin: the provide study. Y. Horsmans (1), I. Jacobson (2), J. Vierling (3), S. Flamm (4), S. Gordon (5), E. Lawitz (6),
J.P. Bronowicki (7), M. Davis (8), E. Yoshida (9), L. Pedicone (10), W. Deng (10), M. Treitel (10), C. Brass (10), J. Albrecht (10), F. Poordad (11) / [1] Uc l St Luc, Brussels, [2] Weill Cornell Medical College, New York, Usa, [3] Baylor
College of Medicine, Houston, USA , [4] Northwestern Feinberg School of Medicine, Chicago, USA , [5] Henry Ford Hospital, Detroit, USA , [6] Alamo Medical Research, San Antonio, USA , [7] University Henri Poincare, Vandoeuvre-lès-Nancy, France, [8] South Florida Center of Gastroenterology, Wellington, USA , [9] University of British Columbia and Vancouver General Hospital, Canada, [10] Merck, Whitehouse Station, USA , [11] Cedars- Sinai Medical Center, Los Angeles, USA
Resource use and cost of hepatitis C related care in Belgium.
F. Nevens (1), I. Colle (2), P. Michielsen (3), G. Robaeys (4), C. Moreno (5),
K. Caekelbergh (6), M. Lamotte (6), V. Wyffels (7) / [1] Kuleuven, [2] Uzgent, [3]
Uz Antwerpen, [4] Zol, Genk, [5] Ulb Erasme, Brussels, [6] IMS Consulting Group,
Vilvoorde, [7] Janssen-Cilag NV, Beerse
Search for an objective parameter of the severity of polycystic liver disease.
F. Temmerman, R. Vanslembrouck, W. Coudyzer, B. Bammens, W. Laleman, D. Cassiman, C. Verslype, W. Van Steenbergen , J. Van Pelt, J. Pirenne, F. Nevens / KUL euven
Outcome after liver transplantation using dcd donors: a singlecenter experience.
D. Monbaliu, J. Francois, S. Vandenbussche, R. Aerts, W. Laleman, C. Verslype, S. Vandermerwe, W. Van Steenbergen, D. Cassiman, F. Nevens,
J. Pirenne / KUL euven
"What you should know about pediatric hepatology"
G. Mieli-Vergani / London, UK
"Prognostic factors in liver biopsy for HCC."
J. Zucman-Rossi / Paris, France
"Staging and local treatment of HCC."
B. Op de Beeck / UZAntwerpen
"Indications for transplantations and
management of HCC while on waiting list".
J..F. Dufour /Bern, Switzerland
"Medical treatment of advanced HCC."
C. Verslype / KULeuven
"Pathophysiology of portal hypertension."
H. Reynaert / UZ Brussel
"Management of acute variceal bleeding and GAVE."
O. Le Moine / UL B Erasme, Brussels
"Primary and Secondary prophylaxis of variceal
bleeding."
P. Stärkel / UCL St Luc, Brussels
"Management of children with GI haemorrhage
due to portal Hypertension."
X. Stéphenne / UCL St Luc, Brussels
.
"Ascites and hyponatremia."
S. Francque / UZ Antwerpen
"Renal dysfunction in cirrhosis."
M. Wissing / UZ Brussel
"Spontaneous bacterial peritonitis and other infections."
T. Gustot / UL B Erasme, Brussels
"Hepatopulmonary syndrome and portopulmonary hypertension."
H. Van Vlierberghe / UZGent
"Coagulation disorders in cirrhosis (hypo and hyper)."
J. Schouten / Rotterdam, Netherlands
(For members only, password necessary)
Ask for your login and password at info@basl.be)
Chronic hepatitis C : case studies in dual and triple therapies
by Prof. Stanislas Pol (Paris, France)
Practical management of patients with DAAs
by Prof. Christophe Hézode (Créteil, France)
Pruritus in cholestatic liver disease
Speaker : Prof. Ulrich Beuers (Amsterdam, The Netherlands)
Viral resistances: similarities and differences between HCV-HBV-HIV
by Prof. Anna Maria Geretti (London)
Hepatocellular carcinoma: resection as a selection tool for liver transplantation
by Prof. Olivier Rosmorduc (Paris, France)
Long-term patient management : protecting the future for patients with HBV
by Prof. Stanislas Pol (Paris, France)
Tenofovir: 5 year's data in chronic hepatitis B infection, focus on histological improvement
by Prof. Pietro Lampertico (Milan, Italy)
The role of VEGF and PIGF in the hepato-pulmonary syndome
by Ch. Van Steenkiste
Function of IL17 in alcoholic liver disease
by R Ouziel
CLINICAL CASES
Family matters (I. Maurissen)
An unusual case of ascites recurrence in a cirrhotic patient (C. Snauwaert)
Hepatitis and headache (L. Van Overbeke)
A cryptic case of encephalopathy (J. Verbeek)
A rare presentation of a rare disease (B Legius)
(For members only, password necessary)
What should the hepatologist know about liver transplant surgery and graft allocation -
O. Detry (ULg)
Immunosuppression and rejection – S. Francque (UA)
Viral hepatitis and transplantation – C. Moreno (ULB)
Long term medical comorbidities after liver transplantation and their management -
I. Colle (UG)
Hepatocellular carcinoma : management of patients on the waiting list – J. Delwaide (ULg)
De novo malignancies following liver transplantation: impact and recommendations -
Z. Hassoun (UCL)
Surgical complications – J. Pirenne (KUL)
(For members only, password necessary)
Differential effects of fatty acids or tunicamycin-induced endoplasmic
reticulum stress on inflammation and insulin resistance in hepg2 cells.
V. Legry, O. Molendi-Coste, I. Leclercq / UCL.
Liver mesenchymal cells contribute to improvement of human
cryopreserved hepatocytes survival and function.
A.C. Dusabineza (1), D. Ngoc Khuu (1), L. Dolle (2), J. Abarca-Quinones (1), E. Sokal (1), L. Van Grunsven (2), M. Najimi (1), I. Leclercq (1) / [1] UCL Saint-Luc, [2] UZ VUB
Mitochondrial uncoupling inhibits activation of hepatic stellate cells.
E. Guimarães, L. Van Grunsven / UZ VUB
Farnesylthiosalicylic acid induces apoptosis and sensitizes
hepatocarcinoma cell lines to doxorubicin and trail-induced cell death.
N. Charette, C. De Saeger, Y. Horsmans, I. Leclercq, P. Starkel / UCL Saint-Luc.
A murine and human study demonstrating the role of plgf in
hepatocellular carcinoma.
F. Heindryckx, S. Coulon, L. Libbrecht, C. Van Steenkiste, A. Geerts, I. Colle,
H. Van Vlierberghe / UZ Gent.
Common polymorphism in the pnpla3/adiponutrin gene confers
higher risk of cirrhosis and liver damage in alcoholic liver disease
E. Trépo, T. Gustot, D. Degré, A. Lemmers, L. Verset, P. Demetter, R. Ouziel, E. Quertinmont, V. Vercruysse, L. Amininejad, O. Le Moine, J. Devière, D. Franchimont,
C. Moreno / UL B Erasme.
Insulin resistance confers a higher risk of portal hypertension,
cirrhosis and early mortality to alcoholic liver disease patients .
E. Trépo (1), D. Degré (1), A. Lemmers (1), T. Gustot (1), A. Gerkens (1), E. Sylvie (1), R. Ouziel (1), P. Deltenre (2), M. Adler (1), J. Devière (1), C. Moreno (1) / [1] UL B Erasme, [2] Hôpital de Jolimont, Haine-Saint-Paul.
Donation after cardiac death increases the number of liver grafts for
liver transplantation.
H. Le Dinh, M. Hans, J. Monnard, M.H. Delbouille, A. Deroover, J. Delwaide, A. Lamproye, S. Lauwick, P. Honoré, O. Detry / CHU Liège.
99mtc-mebrofenin clearance of the future remnant liver is an
accurate tool to predict liver failure after hepatectomy.
T. Chapelle, G. Roeyen, K. De Greef, N. Boeykens, B. Op De beeck, I. Huyghe, T. Lambrechts, A. Verbruggen, D. Ysebaert / UZ Antwerpen.
Diagnosis of hepatic nodules < 20mm in chronic liver disease.
histologic validation of ct and mri criteria.
T. Serste (1), V. Barrau (2), V. Ozenne (2), M.P. Vuilerme (2), O. Farges (2), D.C. Valla (2), V. Paradis (2), V. Vilgrain (2), F. Degos (2) / [1] UL B Saint-Pierre, [2] Hôpital Beaujon, Clichy, France.
Coutcome of patients with hepatocellular carcinoma listed for liver
transplantation before and after the meld-based allocation system
within eurotransplant. a belgian multicentre retrospective study.
B. Vos (1), S. Rogge (2), F. Nevens (3), J. Pirenne (3), J. Lerut (4), O. Ciccarelli (4), H. Van Vlierberghe (2), R. Troisi (2), C. Moreno (1), V. Lucidi (1), V. Donckier (1), J. Delwaide (5), O. Detry (5), P. Michielsen (6),
T. Chapelle (6), M. Adler (1) / [1] UL B Erasme, [2] UG ent, [3] KUL euven, [4] UCL, [5] CHU Liège, [6] UZ Antwerpen.
Altered expression of glucose and lipid regulatory genes in liver tissue in relation
to the severity of non-alcoholic fatty liver disease in a large patient cohort.
S. Francque (1), A. Verrijken (1), J. Prawitt (2), S. Caron (2), I. Mertens (1), E. Van Marck (1), G. Hubens (1), P. Pelckmans (1), P. Michielsen (1), B. Staels (2), L. Van Gaal (1) / [1] UZ Antwerpen, [2] Institut Pasteur, Lille, France
Highly expressed ccl-2 in severe form of alcoholic hepatitis: a
potential enhancer of the il-17- neutrophil liver recruitment pathway.
D. Degré, A. Lemmers, T. Gustot, E. Trépo, R. Ouziel, P. Demetter, L. Verset, E. Quertinmont, V. Vercruysse, O. Le Moine, J. Devière, C. Moreno / UL B Erasme.
Mir141 and mir200c regulate progenitor cell features in
hepatocellular carcinomas.
O. Govaere (1), J. Berkers (1), L. Van Kempen (2), K. Van Den eynde (1), B. Spee (1), R. Aerts (1), B. Topal (1), F. Nevens (1), E. Lerut (1), J. Van Den oord (1), T. Roskams (1) / [1] KUL euven, [2] Jewish General Hospital, Montreal, Canada..
The BASL-BLIC Spring Meeting Lecture:
“Ethics in clinical research” V. Bertele / Milan, Italy.
Practice - an observational trial assessing the efficacy of pegintron®
and rebetol® according to liver fibrosis in naive genotype 1/4/5/6 chronic hepatitis c patients.
S. Bourgeois (1), J. Delwaide (2), P. Deltenre (3), J. Henrion (3), M. Adler (4), P. Langlet (5), J. Mulkay (6), F. Nevens (7), C. Brixko (8), N. Botembe (9), I. Colle (10), H. Reynaert (11), G. Robaeys (12), P. Golstein (4), C. Moreno (4) / [1] ZNA Stuivenberg, Antwerpen, [2] CHU Sart Tilman, Liège, [3] Hôpital de Jolimont, Haine-Saint-Paul, [4] UL B Erasme, Brussels, [5] CHU Brugmann, Brussels, [6] CHU Saint-Pierre, Brussels, [7] KUL euven [8] CHC de la Citadelle, Liège, [9] Centre Hospitalier des Ardennes, Libramont, [10] UZ Gent, [11] UZ VUB, Brussels, [12] Ziekenhuis Oost-Limburg, Genk
Beta-blockers cause paracentesis-induced circulatory dysfunction in
patients with cirrhosis and refractory ascites.
T. Serste (1), C. Francoz (2), F. Durand (2), P.E. Rautou (2), C. Mélot (3), D.C. Valla (2), R. Moreau (2), D. Lebrec (2) / [1] UL B Saint-Pierre, [2] Hôpital Beaujon, Clichy, France, [3] UL B Erasme.
Embolization of spontaneous portosystemic shunts in cirrhotic
patients with refractory hepatic encephalopathy : results of a single
center prospective exploratory study.
K. Ameloot, W. Laleman, S. Heye, J. Vaninbrouckx, C. Verslype, D. Cassiman, J. Fevery, G. Maleux, F. Nevens / KUL euven.
Intra-arterial treatment with yttrium-90 microspheres for hepatocellular
carcinoma: 4 years experience in uz gent.
B. Lambert, E. Sturm, H. Van Vlierberghe, J. Mertens, P. Smeets, R. Troisi, L. Defreyne / UZ Gent.
In vitro hepatogenic differentiation increases adult human liver
progenitor cell susceptibility to hepatitis b virus infection.
M. Paganelli, D.N. Khuu, N. Jazouli, F. André, B. Kabamba, P. Goubau, M. Najimi, E.M.
Sokal / UCL Saint-Luc.
Marc Hautekeete lecture: «Hepatitis E»
N. Kamar /Toulouse, France.
Increasing the tolerance for warm ischemia of livers in transplantation
by the leuven drug protocol.
K. Vekemans, D. Monbaliu, E. Balligand, V. Heedfeld, J. Pirenne, J.F. Van Pelt / KUL euven.
Long-term outcome of patients with polycystic liver disease treated
with lanreotide.
F. Nevens (1), M. Chrispijn (2), R. Vanslembrouck (1), M.H. Van Oijen (2), W. Coudyzer (1), A. Hoffmann (2), H. Dekker (2), R.A. De Man (2), L. Van Keimpema (2), J.H. Drenth (2) / [1] KUL euven,[2] UMC St. Radboud, Nijmegen, Netherlands.
(For members only, password necessary)
Challenges in the treatment of chronic HCV : to treat or not to treat? When to treat and how
(Prof. Philippe Mathurin) invited by MSD-Schering-Plough
Baveno 2010 (Prof.Yves Horsmans) invited by Eumedica
The good, the bad and the imposter : irreversibly tricked by a blind trust in technology. (De Vlieger et al.)
Liver and brain: is there a link? (Orlent et al.)
(For members only, password necessary)
Drug-induced liver disease (A. Geubel, UCL)
NAFLD/NASH (M. Adler, ULB)
Hemochromatosis (J. Delwaide, ULg)
High ferritin, differential diagnosis (H. Van Vlierberghe, UG)
Rare but interesting metabolic diseases (D. Cassiman, KULeuven)
Vascular liver diseases (H. Reynaert, VUB)
Focal liver lesion in a noncirrhotic liver (P. Michielsen, UA)
(For members only, password necessary)
Characterization of the liver progenitor cell niche in liver diseases; potential involvement of wnt and notch signaling. (B. Spee et al.)
Presence of liver angiogenesis and upregulation of the vascular
endothelial growth factor (VEGF ) in a mice model of non-alcoholic steatohepatitis (NASH). (S. Coulon et al)
Activation of the liver progenitor cell compartment is not sufficient
to ensure liver regeneration. (A.C. Dusabineza et al.)
N-glycosylation patterns in hcc-mice chronically injected with den
and their evolution after treatment with anti-plgf. (B. Blomme et al.)
The ras inhibitor farnesylthiosalicylic acid inhibits egf and
igf2-induced cell growth in hepatocarcinoma cell lines. (N. Charette et al.)
Liver progenitor cell expansion in the injured mouse liver: do Kupffer cells play a role? (N. Van Hul et al.)
Management and outcome of biliary complications after liver transplantation.
(S. Van Cleven et al.)
Consequences of laparoscopy on liver ischemia during portal triad clamping in a swine model. (N. Gilson et al.)
Liver transplantation for alcoholic liver disease: a retrospective analysis
of recidivism, survival and risk factors predisposing to alcohol relapse. (E. Deruytter et al.)
Early transplantation improves survival of non-responders to corticosteroids
in severe alcoholic hepatitis: a challenge to the 6 month rule of abstinence. (C. Moreno et al.)
The BASL -BLIC Spring Meeting Lecture:
“Apoptosis, from bench to bedside.” Prof. Marc Bilodeau
Impact of tight glycemic control in patients with decompensated
chronic liver disease admitted to intensive care: results of a
single-centre randomized controlled trial. (W. Laleman et al.)
Liver histology according to the presence of the metabolic syndrome
in overweight and obese patients. (A. Verrijken et al.)
Nafld liver fat score strongly correlates with histological severity of
nafld and nash in a large cohort of prospectively included overweight
patients. (S. Francque et al.)
Liver transplantation using grafts from donors older than seventy
and eighty years old. (T. Darius et al.)
Urgent early (≤ 15 days) arterial revascularization following hepatic
artery thrombosis may avoid graft loss and improve outcome in adult
liver transplantations. (A. Scarinci et al.)
Outcome of patients with hepatocellular carcinoma listed for liver
transplantation before and after the meld allocation system. (
B. Vos et al.)
Report (GL EM-LOK ) on current Barrett’s esophagus management in
Belgium : comments and recommendations. (R. Bisschops et al.)
(For members only, password necessary)
TACE in hepatocellular carcinoma: disease outcome, tumor recurrence and role of angiogenesis. Prof Lencioni ( Pisa, Italy)
Case : Post-vaccination severe autoimmune hepatitis leading to transplantation. A Gerkens, E François, V Lucidi et al.
Case : A young man with multiple adenomas and a hepatocellular carcinoma. D. Cassiman, L. Libbrecht, C Verslype et al.
Managing HBV: 3 years clinical experience with entecavir in Erasmus MC. J. Schouten ( Rotterdam).
New molecules for the treatment of HCV. S. Zeuzem ( Frankfurt, Germany).
(For members only, password necessary)
Pathophysiology of ACLF, predictors of survival and possible treatment options (W. Laleman)
Pathophysiology of ascites and diagnosis of ascites (P. Michielsen)
Treatment of ascites, refractory ascites and spontaneous bacterial peritonitis (H. Reynaert)
Challenging case of renal insufficiency and hyponatremia (M. Adler)
Dyspnea in a patient with cirrhosis (I. Colle)
Cardiac dysfunction in cirrhosis (P. Stärkel)
Challenging case of adrenal dysfunction in cirrhosis (J. Delwaide)
Pregnancy and the Liver (A. Geubel)
(For members only, password necessary)
Spring Meeting : authorized presentations
(For members only, password necessary)
Winter Meeting : all presentations
Liver Course : Autoimmune Liver Diseases : all presentations
Signal transduction pathways and pathogenesis of HCC.
HBV reactivation in chemo- and immunotherapy.
Deficiency in Placental Growth Factor causes a decreased porto-systemic collateral vessel formation in portal hypertensive mice.
Prognostic features in acute-on-chronic alcoholic liver failure.
Abstracts BASL Spring Meeting
Managing unusual side effects of pegylated interferon therapy
Hot topics in Hepatology 2007
Hyponatremia: pathophysiology, treatment, prognostic value
Acute viral hepatitis
Vaccination and post-exposure prophylaxis
Management of chronic hepatitis C
Management of acute cholecystitis and cholangitis
Epidémiologie de l’hépatite B en Europe et panorama des nouvelles approches thérapeutiques.
(.pdf 2.1 Mo)
Prise en charge du patient porteur du virus B : recommendations de la BASL 2007.
(.pdf 0.6 Mo)
(For members only, password necessary)
Pharmacotherapy and lifestyle modifications for obesity and
metabolic syndrome: "What the hepatologist should know ” (pdf, 4.426 Ko)
L. Van Gaal (Antwerp).
Hot shots in Hepatology 2006 (pdf, 1.013 Ko) I. Colle.
Case 1: Fulminant hepatitis (pdf, 1.168 Ko)
Case 2: Special hepatitis (pdf, 2.216 Ko).
Case 3: Portal vein thrombosis (pdf, 314 Ko).
Case 4: A liver transplant patient (pdf, 1.016 Ko.
Case 5: Skin rash and recurrent jaundice (pdf, 437 Ko).
Case 6: ITPA-polymorphism in a liver transplant patient (pdf, 305 Ko).
Case 7: Strange Belgian policy (pdf, 992 Ko).
Please see our newsletter September 2007
Please see our newsletter September 2007
Click here for some reports about the meeting.
Click here for some reports about the meeting.
Click here for A. Geubel's lecture on drugs' hepatotoxicity (zip/ppt file).
Click here for some reports about the meeting.
Click here for a report about the meeting.
Click here for some reports about the meeting.
Click here for some reports about the meeting.
|
|